申请人:Mochida Pharmaceutical Co., Ltd.
公开号:EP2703393A1
公开(公告)日:2014-03-05
[Problem]
To provide a GPR40 activating agent having, as an active ingredient, a novel compound having a GPR40 agonist action, a salt of the compound, a solvate of the salt or the compound, or the like, particularly, an insulin secretagogues and a prophylactic and/or therapeutic agent against diabetes, obesity, or other diseases.
[Means of solving the problem]
A compound of Formula (I):
(where n is 0 to 2; p is 0 to 4; his 0 to 3; j is 0 to 3; k is 0 to 2; a ring B is an aryl group or a heteroaryl group; X is O, S, or -NR7-; J1 is -CR11aR11b- or -NR11c-; J2 is -CR12aR12b- or -NR12c-; and R1 to R12c are specific groups),
a salt of the compound, or a solvate of the salt or the compound.
问题
提供一种GPR40激活剂,其有效成分为具有GPR40激动剂作用的新型化合物、该化合物的盐、该盐或该化合物的溶液或类似物,特别是一种胰岛素促泌剂和糖尿病、肥胖症或其他疾病的预防和/或治疗剂。
[解决问题的方法]
一种式(I)化合物:
(其中 n 为 0 至 2;p 为 0 至 4;his 为 0 至 3;j 为 0 至 3;k 为 0 至 2;环 B 为芳基或杂芳基;X 为 O、S 或-NR7-;J1 为-CR11aR11b-或-NR11c-;J2 为-CR12aR12b-或-NR12c-;R1 至 R12c 为特定基团)、
该化合物的盐,或该盐或该化合物的溶液。